Pubblicazioni

5-alpha reductase inhibitors (5-ARi) with or without alpha-blockers (Î±-B) for Benign Prostatic Hyperplasia do NOT lower the risk of incident Bladder Cancer: United States insurance claims data

2023 - WORLD JOURNAL OF UROLOGY

Del Giudice, Francesco; Belladelli, Federico; Glover, Frank; Basran, Satvir; Li, Shufeng; Mulloy, Evan; Pradere, Benjamin; Soria, Francesco; Krajewski, Wojciech; Nair, Rajesh; Muncey, Wade; Seranio, Nicolas; Eisenberg, Michael L